Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | AKR1C3 | P42330 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 3/20 | 0.45 |
| ▸ | SFRP1 | Q8N474 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4902713 | 0.88 | PKM (0.52) | ALDH1A1SMN1; SMN2MEN1KMT2AGAA | |
| SCHEMBL4907671 | 0.86 | ALDH1A1 (0.53) | ALDH1A1SMN1; SMN2MEN1KMT2AGAA | |
| SCHEMBL4902977 | 0.85 | MAPT (0.54) | ALDH1A1SMN1; SMN2MEN1KMT2AAKR1C3 | |
| SCHEMBL4906132 | 0.85 | ALDH1A1 (0.58) | ALDH1A1SMN1; SMN2MEN1KMT2AAKR1C3 | |
| SCHEMBL4895776 | 0.85 | ALDH1A1 (0.55) | ALDH1A1SMN1; SMN2AKR1C3MAPTLMNA | |
| SCHEMBL4903854 | 0.84 | ALDH1A1 (0.48) | ALDH1A1SMN1; SMN2MEN1KMT2AGAA | |
| SCHEMBL4905550 | 0.84 | ALDH1A1 (0.51) | ALDH1A1SMN1; SMN2MEN1KMT2AAKR1C3 | |
| SCHEMBL4906567 | 0.84 | MMP2 (0.52) | ALDH1A1SMN1; SMN2AKR1C3MAPTLMNA | |
| SCHEMBL4903953 | 0.83 | PKM (0.48) | ALDH1A1SMN1; SMN2MEN1KMT2AGAA | |
| SCHEMBL4904696 | 0.83 | MAPT (0.49) | ALDH1A1SMN1; SMN2MEN1KMT2AAKR1C3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080090829-A1 | SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS | PFIZER INC. | 2008-04-17 | — | — | US | disclosed |
| US-20080090829-A1 | SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS | PFIZER INC. | 2008-04-17 | — | — | US | disclosed |
| US-20080090829-A1 | SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS | PFIZER INC. | 2008-04-17 | — | — | US | disclosed |
| US-20060229363-A1 | Substituted Heteroaryl- and Phenylsulfamoyl Compounds | HAMANAKA ERNEST S | 2006-10-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060229363-A1 | Substituted Heteroaryl- and Phenylsulfamoyl Compounds | PPARA, PPARG, PPARD | ALDH1A1 2664/4885SMN1; SMN2 3271/4885MEN1 4859/4885 |
| US-20080090829-A1 | SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS | PPARA, PPARG, PPARD | ALDH1A1 2956/4885SMN1; SMN2 3404/4885MEN1 4855/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.